Immunogenicity of the Quadrivalent Human Papillomavirus (Type 6/11/16/18) Vaccine in Males 16 to 26 Years Old

Human papillomavirus (HPV) infection can lead to significant disease in males, including anogenital warts, intraepithelial neoplasias, and several types of oral and anogenital cancers. The quadrivalent HPV (type 6/11/16/18) L1 virus-like particle (VLP) vaccine (qHPV vaccine; Gardasil) has recently b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hillman, Richard J., Giuliano, Anna R., Palefsky, Joel M., Goldstone, Stephen, Moreira, Edson D., Vardas, Eftyhia, Aranda, Carlos, Jessen, Heiko, Ferris, Daron G., Coutlee, Francois, Marshall, J. Brooke, Vuocolo, Scott, Haupt, Richard M., Guris, Dalya, Garner, Elizabeth I. O.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2012
Assuntos:
Vaccines
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3272915/
https://ncbi.nlm.nih.gov/pubmed/22155768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.05208-11
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados